Skip to content
Screener

Atossa Therapeutics, Inc. ATOS Q1 2026 earnings

Reported May 8, 2026 · Before market open

EPS-$1.11Beat by $0.11
EPS estimate-$1.22

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.92

FAQ

When did Atossa Therapeutics, Inc. report Q1 2026 earnings?
Atossa Therapeutics, Inc. (ATOS) reported Q1 2026 earnings on May 8, 2026 before market open.
What were Atossa Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Atossa Therapeutics, Inc. reported eps of $-1.11 for Q1 2026.
Did Atossa Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-1.22 by $0.11.
How did Atossa Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 2120.0% from $-0.05.
Where can I find Atossa Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-213373) and the 10-Q periodic report (0001193125-26-213423) directly on SEC EDGAR. The filing index links above go to sec.gov.